Trial Profile
An Exploratory, Randomised, Double-blind, Placebo-controlled, Parallel Group, Pilot Study to Assess the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets (OXN PR) Compared to Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Pain
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- Sponsors Mundipharma GmbH
- 18 Jul 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database
- 01 Mar 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2013 Planned end date changed from 1 Oct 2012 to 1 May 2013 as reported by ClinicalTrials.gov.